crefmirlimab berdoxam
i-mab
['advance', 'imab ']
next up at #sitc22 is s . assessing the correlation between cd8 cell pet imaging with 89-zr-crefmirlimab berdoxam and cd8 cell immunohistochemistry in patients with advanced cancer receiving immunotherapy. 